Výsledky vyhledávání - "Gottschalk CH"

Akademický článek

Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.

Autor: Lipton RB; Department of Neurology and Headache Center, Albert Einstein College of Medicine, Bronx, NY., Gandhi P; AbbVie, Madison, NJ., Tassorelli C; Department of Brain and Behavioral Sciences, University of Pavia, Italy.; Headache Science and Neurorehabilitation Centre, IRCCS C. Mondino Foundation, Pavia, Italy., Reuter U; Department of Neurology and West German Headache Center, University Hospital Essen, Germany., Harriott AM; Massachusetts General Hospital, Boston, MA., Holle-Lee D; Charité University Hospital of Berlin, Germany.; University Hospital Greifswald, Germany., Gottschalk CH; Division of General Neurology, Yale School of Medicine, New Haven, CT., Neel B; AbbVie, Irvine, CA., Liu Y; AbbVie, North Chicago, IL; and., Guo H; AbbVie, Madison, NJ., Stokes J; AbbVie, Madison, NJ., Nagy K; AbbVie, Budapest, Hungary., Dabruzzo B; AbbVie, Madison, NJ., Smith JH; AbbVie, North Chicago, IL; and.

Publikováno v: Neurology [Neurology] 2025 Jan 28; Vol. 104 (2), pp. e210212. Date of Electronic Publication: 2024 Dec 23.

Zobrazit plný text záznamu

Akademický článek

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.

Autor: Schindler EAD; Department of Neurology, Yale School of Medicine, New Haven, CT, United States of America; Neurology Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America; Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America. Electronic address: emmanuelle.schindler@yale.edu., Sewell RA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America., Gottschalk CH; Department of Neurology, Yale School of Medicine, New Haven, CT, United States of America., Flynn LT; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America., Zhu Y; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America., Pittman BP; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America., Cozzi NV; Neuropharmacology Laboratory, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America; Alexander Shulgin Research Institute, Lafayette, CA, United States of America., D'Souza DC; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America.

Publikováno v: Journal of the neurological sciences [J Neurol Sci] 2024 May 15; Vol. 460, pp. 122993. Date of Electronic Publication: 2024 Apr 02.

Zobrazit plný text záznamu

Editorial & Opinion

Migraine-Not Just a Numbers Game: Aim to Improve Quality of Life.

Autor: Kopel D; From the Lexington Neurology (D.K.), Lexington Medical Center, West Columbia, SC; and Headache Medicine (C.H.G.), General Neurology (C.H.G.), Department of Neurology, Yale University., Gottschalk CH; From the Lexington Neurology (D.K.), Lexington Medical Center, West Columbia, SC; and Headache Medicine (C.H.G.), General Neurology (C.H.G.), Department of Neurology, Yale University. chris.gottschalk@yale.edu.

Publikováno v: Neurology [Neurology] 2023 Feb 21; Vol. 100 (8), pp. 357-358. Date of Electronic Publication: 2022 Nov 17.

Zobrazit plný text záznamu

Akademický článek

Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.

Autor: Schindler EAD; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; Neurology Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.; Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Sewell RA; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Gottschalk CH; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA., Luddy C; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Flynn LT; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Zhu Y; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Lindsey H; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; Neurology Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.; Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA., Pittman BP; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA., Cozzi NV; Neuropharmacology Laboratory, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Alexander Shulgin Research Institute, Lafayette, California, USA., D'Souza DC; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.

Publikováno v: Headache [Headache] 2022 Nov; Vol. 62 (10), pp. 1383-1394. Date of Electronic Publication: 2022 Nov 23.

Zobrazit plný text záznamu

Akademický článek

Characterizing the providers of and reimbursement for chronic migraine chemodenervation among the Medicare population.

Autor: Torabi SJ; Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA., Kasle DA; Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA., Savoca EL; Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA., Gottschalk CH; Division of Headache Medicine, Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Manes RP; Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.

Publikováno v: Headache [Headache] 2021 Feb; Vol. 61 (2), pp. 373-384. Date of Electronic Publication: 2020 Dec 18.

Zobrazit plný text záznamu

Akademický článek

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

Autor: Schindler EAD; Department of Neurology, Yale School of Medicine, New Haven, CT, USA. emmanuelle.schindler@yale.edu.; Neurology Service, Veterans Affairs Connecticut Healthcare System, MS 127, 950 Campbell Avenue, West Haven, CT, 06516, USA. emmanuelle.schindler@yale.edu.; Veterans Affairs Headache Center of Excellence, West Haven, CT, USA. emmanuelle.schindler@yale.edu., Sewell RA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA., Gottschalk CH; Veterans Affairs Headache Center of Excellence, West Haven, CT, USA., Luddy C; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA., Flynn LT; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA., Lindsey H; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.; Neurology Service, Veterans Affairs Connecticut Healthcare System, MS 127, 950 Campbell Avenue, West Haven, CT, 06516, USA.; Veterans Affairs Headache Center of Excellence, West Haven, CT, USA., Pittman BP; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA., Cozzi NV; Neuropharmacology Laboratory, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Alexander Shulgin Research Institute, Lafayette, CA, USA., D'Souza DC; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.

Publikováno v: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2021 Jan; Vol. 18 (1), pp. 534-543. Date of Electronic Publication: 2020 Nov 12.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání